Anxiety Disorders and Depression Treatment Market Analysis by Drug Classes and Industrial Forecast 2020
Get the Sample Report for Future Market Trends of Anxiety Disorders and Depression Treatment at: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1199
The market overview chapter, which has been provided in the study, analyzes the current market dynamics and other trends such as drivers, restraints, opportunities that would govern the present and future circumstances of the anxiety disorder and depression treatment market. Furthermore, Porter’s five forces analysis has been incorporated in this research to provide the competitive status of the anxiety disorders and depression treatment market; and market attractiveness analysis has been included to describe the market position across various geographies. Event impact analysis has been provided in this report for better understanding the significant events that have taken place in the past and are planned for the future and which might have a major impact on industry growth. Regulatory framework has also been discussed in this section to provide an overall idea about the regulatory scenario across the major geographies.
This research on anxiety disorders and depression treatment has been categorized based on various classes of drugs that are generally used for the treatment of these psychiatric conditions. Various drug classes considered while estimating the overall market are selective serotonin reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs), tetracyclic antidepressants (TeCAs), monoamine oxidase inhibitors (MAOIs), tricyclic antidepressants (TCAs), benzodiazepines, beta-blockers, atypical antipsychotics and anticonvulsants. The market for these drug classes has been comprehensively analyzed based on the expiry, launch, sales revenue, efficacy and geographic presence of leading drugs in each of the classes mentioned above. Market revenue (USD million) for each of these drug classes has been provided in the research for the period 2012 to 2020 in terms of USD million, with CAGR for the forecast period 2014 to 2020, taking into account 2013 as the base year.
In terms of geography, the global anxiety disorders and depression treatment market has been categorized into four major regions: North America, Europe, Asia Pacific and Rest of the World (RoW). In the geography section of the report, the market revenue (USD million) of various drug classes used for the treatment of anxiety disorders and depression for each of these geographic regions for 2012 and 2020 along with forecast period from 2014 to 2020 has been provided and explained in detail.
Read the Current Market Status of Anxiety Disorders and Depression Treatment at: http://www.transparencymarketresearch.com/anxiety-disorders-depression-treatments.html
The chapter on competitive landscape included in the report provides a detailed market share analysis of the major leading companies in the anxiety disorders and depression treatment market, in terms of percentage share for the year 2013. The detailed market share analysis of the industry participants involved in the market would help new organizations to identify the product portfolio of established global players and understand the business plans followed by key companies for sustaining in the market. Several pointers on strategic recommendations have also been provided for new industry participants as well as established organizations to help in securing a strong position in the global market and improve market share. Furthermore, the research comprises a chapter on pipeline analysis for this industry that includes sales forecast for recently launched drugs and potential drugs that are undergoing phase III clinical trials and are expected to be marketed during the forecast period.
The report provides in-depth company profiles of major players in the anxiety disorders and depression treatment market based on a variety of characteristics such as company overview, financial overview, product portfolio, business strategies and recent developments. Major players profiled in this study include AstraZeneca plc, Eli Lilly and Company, Forest Laboratories, Inc., Johnson and Johnson, GlaxoSmithKline plc, H. Lundbeck A/S, Pfizer, Inc., Merck & Co., Inc. and Sanofi S.A.
Transparency Market Research (TMR) is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
90 State Street, Suite 700
Albany, NY 12207
USA - Canada Toll Free: 866-552-3453
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Anxiety Disorders and Depression Treatment Market Analysis by Drug Classes and Industrial Forecast 2020 here
News-ID: 429613 • Views: 377
More Releases from TMR - Research Reports
Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2 …
According to the research report, the global pulmonary drugs market is expected to be worth US$ 28,082.1 mn by the end of 2024 as compared to US$ 48,039.7 mn in 2015. Analysts calculate that the global market will plummet at a CAGR of -6.3% during the forecast period of 2016 and 2024. The market will thrive as the demand for combination drugs is anticipated to remain on the rise during
North America Ventricular Assist Device Market is rising to a valuation of US$ 1 …
According to TMR, the opportunity in the North America market for VADs, which stood at US$0.4 bn in 2015, is likely to expand at a healthy CAGR of 9.20% between 2016 and 2024 and increase to US$1.07 bn by the end of the forecast period. The destination therapy (DT) segment has been reporting a greater application of VADs than the other two indication segments. It is expected to remain the
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million b …
Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016. The global dental membrane and bone graft substitutes market is expected to
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period. By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment
More Releases for Anxiety
Free Hypnosis Download for Coronavirus Anxiety
Eli Bliliuos, founder and President, of NYC Hypnosis Center has just released a free hypnosis download to help anyone who is suffering from anxiety and stress due to the Coronavirus pandemic. The free Hypnosis MP3 for Coronavirus Anxiety (24 hours only), called "Clear Your Mind", can provide a break from the repetitive thoughts related to the outbreak. It can help program the mind to recognize that this Coronavirus pandemic will
Generalized Anxiety Disorder (GAD) Market 2023 By Top Players
Generalized anxiety disorder is characterized by excessive anxiety and worry about everyday life events with no apparent reason. The patient cannot stop worrying about health, family, money, or work and eventually anxiety dominates the person thinking, that interfere with daily functioning of person. Symptoms of generalized anxiety disorder includes an unrealistic view of problems, muscle tension, headache, sweating, and tiredness. Additionally, rarely GAD occurs alone as it often
General Anxiety Disorder Market Worldwide Growth by 2020
General Anxiety Disorder Market by Therapeutics (Antidepressant, Benzodiazepines and Others): U.S. Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast 2014 – 2020. U.S. general anxiety disorder market expected to reach USD 3,775 million by end of 2020, growing at a CAGR of 2.4% during 2015 and 2020. The report covers forecast and analysis for the general anxiety disorder market U.S. region. The study provides historic data of 2014 along
General Anxiety Disorder Market Revenue Share, By Therapeutics, 2015 - 2021
Zion Market Research has published a new report titled “General Anxiety Disorder Market by Therapeutics (Antidepressant, Benzodiazepines and Others): U.S. Industry Perspective, Comprehensive Analysis and Forecast, 2014 – 2020.” According to the report, The U.S. demand for general anxiety disorder market was valued at USD 3,251 million in 2014, and is expected to generate revenue of USD 3,775 million by end of 2020, growing at a CAGR of 2.4% between
No Pain, No Anxiety, Exceptional Care
NYC Smile Design finds the perfect balance to patient care, by using the latest advances in dental technology to treat pain and anxiety, and extending its extraordinary cosmetic and technical skills to treating the whole patient. Hailed by Newsweek as “two of Manhattan's most respected and accomplished cosmetic dentists,” Drs. Ramin Tabib and Elisa Mello have perfected a new treatment strategy that guarantees their patients pain-free and relaxed visits to the
IT Manager Uses "Sleep Tracks" to Combat Insomnia and Anxiety
SAN FRANCISCO, California (December 7, 2010) As a new research indicates that software engineeers are working too hard and suffer from job-related stress, insomnia and anxiety, Karl Ramm says he found a viable solution. The California-based technology manager reports listening to specialized audio sessions to alleviate his work-induced stress and anxiety -- and get the sleep he desperately needs. "I was having a lot of anxiety before sleeping and could not